OliX Pharmaceuticals, Inc (KOSDAQ:A226950) agreed to acquire 6.63% stake in PCL, Inc. (KOSDAQ:A241820) for KRW8.04 billion on November 11, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,185 KRW | 0.00% | -1.50% | -66.95% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
15,300 KRW | -0.65% | -2.36% | 186M | ||
1,185 KRW | 0.00% | -1.50% | 47.21M | ||
1st Jan change | Capi. | |
---|---|---|
-66.95% | 47.21M | |
-16.96% | 11.29B | |
-30.43% | 2.29B | |
-11.81% | 2.23B | |
-23.56% | 1.61B | |
+36.79% | 1.19B | |
-3.28% | 752M | |
-12.67% | 545M | |
-36.53% | 458M | |
+13.72% | 338M |
- Stock Market
- Equities
- A241820 Stock
- News PCL, Inc.
- OliX Pharmaceuticals, Inc agreed to acquire 6.63% stake in PCL, Inc. for KRW8.04 billion.